+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Argentina Respiratory Devices Market - Growth, Trends, and Forecasts (2020 - 2025)

  • PDF Icon


  • 75 Pages
  • June 2020
  • Region: Argentina
  • Mordor Intelligence
  • ID: 5120182
The Argentina Respiratory Devices Market is expected to register a CAGR of 2% during the forecast period. This is attributing to the increasing prevalence of respiratory disorders, such as COPD, TB, Asthma, and Sleep Apnea, technological advancements, and large patient population. As per the Global Health Data Exchange, in 2017 approximately 107,106 people are affected by COPD in Argentina. In Addition, the number of new cases for tuberculosis is around 5,826 in this region Thus, the presence of such a large number will demand respiratory devices and drive the market in Argentina. Furthermore, Increasing R&D expenditure by innovators and generic players, technological advancements associated with respiratory devices, and the rising ageing population will also fuel the Argentina respiratory devices Market. However, the high cost associated with the devices may hamper the market to a certain extent

Key Market Trends

Therapeutic devices in Argentina Respiratory Device is Estimated to Witness a Healthy Growth in Future.

Therapeutic devices are estimated to witness healthy growth in the future attributed to the growing prevalence of respiratory disorders, rising chronic diseases, and growing geriatric population. Therapeutic devices comprise of CPAP Devices, BiPAP Devices, Humidifiers, Nebulizers, Ventilators, Oxygen Concentrators, and Inhalers. These are essential in the healing of the respiratory disorder population. The CPAP and BiPAP devices are widely used in obstructive sleep apnea patient population. The rising number of sleep apnea population in Argentina and the availability of reimbursement coverage in this region is expected to fuel the therapeutic device segment growth. This rising prevalence and enhanced patient compliance will likely positively impact segment growth.

Competitive Landscape

The Argentina Respiratory Devices Market is moderately competitive and consists of several major players. Some of the companies which are currently dominating the market are Drägerwerk AG & Co. KGaA, Tecme SA, ResMed, Medtronic, General Electric Company, Chart Industries, Drive DeVilbiss International, Fisher & Paykel Healthcare Limited., GlaxoSmithKline PLC, and Invacare Corporation,

Reasons to Purchase this report:
  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

This product will be delivered within 2 business days.

Table of Contents

1.1 Study Assumptions
1.2 Scope of the Study
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Prevalence of Respiratory Disorders, such as COPD, TB, Asthma, and Sleep Apnea
4.2.2 Technological Advancements
4.2.3 Large Patient Population
4.3 Market Restraints
4.3.1 High Cost of Devices
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5.1 By Type
5.1.1 By Diagnostic and Monitoring Devices Spirometers Sleep Test Devices Peak Flow Meters Pulse Oximeters Others
5.1.2 By Therapeutic Devices CPAP Devices BiPAP Devices Humidifiers Nebulizers Ventilators Oxygen Concentrators Inhalers Others
5.1.3 By Disposables Masks Breathing Circuits Others
6.1 Company Profiles
6.1.1 Drägerwerk AG & Co. KGaA,
6.1.2 Tecme SA
6.1.3 ResMed
6.1.4 Medtronic
6.1.5 General Electric Company
6.1.6 Chart Industries
6.1.7 Drive DeVilbiss International
6.1.8 Fisher & Paykel Healthcare Limited.
6.1.9 GlaxoSmithKline PLC
6.1.10 Invacare Corporation

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Drägerwerk AG & Co. KGaA,
  • Tecme SA
  • ResMed
  • Medtronic
  • General Electric Company
  • Chart Industries
  • Drive DeVilbiss International
  • Fisher & Paykel Healthcare Limited.
  • GlaxoSmithKline PLC
  • Invacare Corporation